In synovial sarcoma, the incorporation of SS18–SSX fusion protein into cBAF, instead of wild-type SS18, results in the ejection of SMARCB1 and its subsequent proteasome-mediated degradation [83]. The gene discussed is SS18; the disease is synovial sarcoma.